Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 88

1.

US6 Gene Deletion in Herpes Simplex Virus Type 2 Enhances Dendritic Cell Function and T Cell Activation.

Retamal-Díaz A, Weiss KA, Tognarelli EI, Freire M, Bueno SM, Herold BC, Jacobs WR Jr, González PA.

Front Immunol. 2017 Nov 10;8:1523. doi: 10.3389/fimmu.2017.01523. eCollection 2017.

2.

Role of CD8+ T cells and lymphoid dendritic cells in protection from ocular herpes simplex virus 1 challenge in immunized mice.

Matundan H, Mott KR, Ghiasi H.

J Virol. 2014 Jul;88(14):8016-27. doi: 10.1128/JVI.00913-14. Epub 2014 May 7.

3.

A Herpes Simplex Virus Type 2 Deleted for Glycoprotein D Enables Dendritic Cells to Activate CD4+ and CD8+ T Cells.

Retamal-Díaz AR, Kalergis AM, Bueno SM, González PA.

Front Immunol. 2017 Aug 9;8:904. doi: 10.3389/fimmu.2017.00904. eCollection 2017.

6.

CD8+ T Cells Play a Bystander Role in Mice Latently Infected with Herpes Simplex Virus 1.

Mott KR, Gate D, Matundan HH, Ghiasi YN, Town T, Ghiasi H.

J Virol. 2016 Apr 29;90(10):5059-5067. doi: 10.1128/JVI.00255-16. Print 2016 May 15.

8.

HSV-2 ΔgD elicits FcγR-effector antibodies that protect against clinical isolates.

Petro CD, Weinrick B, Khajoueinejad N, Burn C, Sellers R, Jacobs WR Jr, Herold BC.

JCI Insight. 2016 Aug 4;1(12). pii: e88529.

9.

Activation of NF-κB in CD8+ dendritic cells Ex Vivo by the γ134.5 null mutant correlates with immunity against herpes simplex virus 1.

Jin H, Ma Y, Yan Z, Prabhakar BS, He B.

J Virol. 2012 Jan;86(2):1059-68. doi: 10.1128/JVI.06202-11. Epub 2011 Nov 9.

10.

Prophylactic and therapeutic modulation of innate and adaptive immunity against mucosal infection of herpes simplex virus.

Uyangaa E, Patil AM, Eo SK.

Immune Netw. 2014 Aug;14(4):187-200. doi: 10.4110/in.2014.14.4.187. Epub 2014 Aug 22. Review.

11.

Herpes simplex type 2 virus deleted in glycoprotein D protects against vaginal, skin and neural disease.

Petro C, González PA, Cheshenko N, Jandl T, Khajoueinejad N, Bénard A, Sengupta M, Herold BC, Jacobs WR.

Elife. 2015 Mar 10;4. doi: 10.7554/eLife.06054.

12.

Novel Role for Interleukin-17 in Enhancing Type 1 Helper T Cell Immunity in the Female Genital Tract following Mucosal Herpes Simplex Virus 2 Vaccination.

Bagri P, Anipindi VC, Nguyen PV, Vitali D, Stämpfli MR, Kaushic C.

J Virol. 2017 Nov 14;91(23). pii: e01234-17. doi: 10.1128/JVI.01234-17. Print 2017 Dec 1.

13.

A live-attenuated HSV-2 ICP0 virus elicits 10 to 100 times greater protection against genital herpes than a glycoprotein D subunit vaccine.

Halford WP, Püschel R, Gershburg E, Wilber A, Gershburg S, Rakowski B.

PLoS One. 2011 Mar 11;6(3):e17748. doi: 10.1371/journal.pone.0017748.

14.
15.

Dok-1 and Dok-2 Are Required To Maintain Herpes Simplex Virus 1-Specific CD8+ T Cells in a Murine Model of Ocular Infection.

Lahmidi S, Yousefi M, Dridi S, Duplay P, Pearson A.

J Virol. 2017 Jul 12;91(15). pii: e02297-16. doi: 10.1128/JVI.02297-16. Print 2017 Aug 1.

16.
17.

The herpes simplex virus type 1 latency-associated transcript inhibits phenotypic and functional maturation of dendritic cells.

Chentoufi AA, Dervillez X, Dasgupta G, Nguyen C, Kabbara KW, Jiang X, Nesburn AB, Wechsler SL, Benmohamed L.

Viral Immunol. 2012 Jun;25(3):204-15. doi: 10.1089/vim.2011.0091. Epub 2012 Apr 18.

18.

Prophylactic Herpes Simplex Virus 2 (HSV-2) Vaccines Adjuvanted with Stable Emulsion and Toll-Like Receptor 9 Agonist Induce a Robust HSV-2-Specific Cell-Mediated Immune Response, Protect against Symptomatic Disease, and Reduce the Latent Viral Reservoir.

Hensel MT, Marshall JD, Dorwart MR, Heeke DS, Rao E, Tummala P, Yu L, Cohen GH, Eisenberg RJ, Sloan DD.

J Virol. 2017 Apr 13;91(9). pii: e02257-16. doi: 10.1128/JVI.02257-16. Print 2017 May 1.

19.

Development of a glycoprotein D-expressing dominant-negative and replication-defective herpes simplex virus 2 (HSV-2) recombinant viral vaccine against HSV-2 infection in mice.

Akhrameyeva NV, Zhang P, Sugiyama N, Behar SM, Yao F.

J Virol. 2011 May;85(10):5036-47. doi: 10.1128/JVI.02548-10. Epub 2011 Mar 9.

20.

The virion host shutoff protein of herpes simplex virus 1 blocks the replication-independent activation of NF-κB in dendritic cells in the absence of type I interferon signaling.

Cotter CR, Kim WK, Nguyen ML, Yount JS, López CB, Blaho JA, Moran TM.

J Virol. 2011 Dec;85(23):12662-72. doi: 10.1128/JVI.05557-11. Epub 2011 Sep 21.

Supplemental Content

Support Center